pharmaceutical – cannabis.co.nz

December 10, 2022Affinity, analysis, analytics, bio, business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, growing, head, industry, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, medical, medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, Quality, regulation, regulatory, safety, state, studies, Study, test, Testing, therapeutics, to, trial, Zelira

First Pharma vs Cannabis Clinical Trial Moves Forward

Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in […]

July 22, 2021ABCann, administration, analysis, analytics, Aphria, Aurora, business, Business Analysis, cannabis, Canopy, cbd, condition, dispensary, Epidiolex, Federal, global, government, growing, GW Pharma, industry, insights, latin america, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicinal, medicine, pharmaceutical, Quality, recreational, regulation, regulations, regulatory, safety, state, supreme, thc, topical, world, worldwide

5 Pivotal Trends Propelling Growth For the Medical Cannabis Market: 2021-2027

Growing awareness and public support for medical cannabis around the world has pushed regulatory authorities to consider the legalization of medical cannabis, […]

May 20, 2021analysis, analytics, blend, blending, bottle, bottling, business, cannabis, capacity, cbd, compliance, Concentrates & Extracts, Edibles & Processing, equipment, extraction, government, grade, industry, manufacturing, marijuana, market, oil, Operations, package, packaging, pharma, pharmaceutical, process, processing, product, Quality, regulation, regulations, regulatory, retail, safety, seal, shape, stainless, state, steel, storage, store, supplier, supply, Sustainability, test, Testing, thc, toggle, transport, transportation, vendor, vessel

CBD Blending, Transportation & Supply – How Sustainable Manufacturing Can Improve Your Cost-Efficiency at all Stages

Environmentally conscious manufacturing has never been more important; for the survival of both the planet and your business. The internet makes CBD […]

October 28, 20201, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]

July 3, 2020adult use, analysis, analytics, Berlin, business, Business Analysis, CANADA, canadian, cannabis, cbd, Cologne, compliance, compliant, consumer, cultivation, delivery, dispensary, distribution, distributor, EU, EU BIO, europe, European, export, extraction, Federal, foreign, France, Frankfurt, German, Germany, GMP, government, grade, grow, grower, growing, grown, import, industry, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, parliament, pharmaceutical, produce, producer, product, production, Quality, recreational, reform, regulation, regulations, regulatory, retail, safety, state, test, thc, UN, union, WHO

A Snapshot of The German Cannabis Market: Year 3

Despite the limitations and privations caused by the COVID-19 pandemic, Germany’s market is “up” in terms of sales and overall insurance approvals. […]

May 30, 2020analysis, analytics, bid, business, Business Analysis, CANADA, Cannabics, cannabis, Canopy Growth, Cantourage, cbd, certification, company, compliance, cultivation, dispensary, EU, europe, export, exporter, exporting, Federal, Germany, GMP, government, growing, Health, import, industry, international, Israel, israeli, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, ministry, pharmaceutical, politic, political, product, Quality, regulation, regulations, regulatory, retail, state, thc

Israeli Begins Granting Export Permits

On May 13, months after the Israeli government originally signed off on cannabis exports, a free export order was finally approved by […]